サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：外科用画像診断の世界市場-2023-2030
市場調査レポート
商品コード
1290360

外科用画像診断の世界市場-2023-2030

Global Surgical Imaging Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
外科用画像診断の世界市場-2023-2030
出版日: 2023年06月12日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

外科用画像診断の世界市場規模は、2022年に20億4,730万米ドルに達し、2030年には最大で3兆3,305億米ドルに達することで有利な成長を示すと予測されます。世界の外科用画像診断市場は、予測期間中（2023年～2030年）に6.4%のCAGRを示すと予想されています。

外科用画像診断は、腫瘍切除、生検処置、リンパ節郭清を含む腫瘍学的手術において極めて重要です。腫瘍外科医は、CT、MRI、PET-CTスキャンなどの画像診断装置を使用することで、腫瘍の位置特定、病期分類、切除範囲の決定などを支援し、外科的アプローチを最適化し、腫瘍の完全切除を保証することができます。

市場力学

慢性疾患の負担増が、予測期間中の外科用画像診断の世界市場の成長を後押ししています

先進国と発展途上国の両方において、慢性非伝染性疾患（NCDs）は死亡と障害の主な原因となっています。世界の死亡者数の10人中7人は、がん、心血管疾患、慢性呼吸器疾患、糖尿病の4つの主要なNCDsによって引き起こされています。NCDに関連する死亡の80%は、低・中所得国で発生しています。

世界保健機関（WHO）の2022年の推計によると、非伝染性疾患（NCD）は、世界の年間死亡者数4,100万人、全死亡者数の74％を占めるとされています。世界で毎年1,700万人が70歳になる前にNCDで亡くなっており、この早すぎる死の86％は低・中所得国で起こっています。

技術的進歩が外科用画像診断市場に有望な成長機会をもたらす

未来の外科手術において、互いの仕事をうまく補完するために、人間とヘルスケアテクノロジーはますます協力し合う必要があります。例えば、2022年1月、医療技術機関であるRoyal Philipsが開発したThe Image-Guided Therapy Mobile C-arm System-Zenitionは、新たに高度な3D画像誘導機能を医師に提供し、臨床精度と効率を高め、血管内治療を受ける患者の結果を改善することを目指すことになります。

COVID-19の影響分析

COVID-19の大流行は、外科用画像診断市場に大きな影響を与えています。パンデミックが外科専門分野に実質的かつ広範囲に影響を及ぼした結果、選択手術が世界的に延期されています。

2022年にJornal of Minimal Access Surgeryに掲載された記事によると、従来の開腹手術と比較して、低侵襲手術（MIS）は小さな切開を採用し、組織への損傷が少なく、出血を最小限に抑え、患者の入院期間を短縮し、優れた短期結果と同等の長期結果をもたらします。このパンデミックに対抗するために、外科医はMISの分野で成功を収めることができると思われます。

ロシア・ウクライナ紛争分析

ロシア・ウクライナ紛争が外科用画像診断市場に与える影響は、複雑かつ多面的です。紛争時には、ヘルスケアのリソースや優先順位が緊急医療や外傷治療にシフトし、緊急性のない処置や外科用画像診断システムのような特殊な機器への焦点や投資が少なくなることがあります。ヘルスケアシステムは、高度な画像処理技術への投資よりも緊急かつ重要なニーズを優先するため、外科用画像診断装置の需要に影響を及ぼします。

目次

第1章 調査手法と範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

  • 製品別スニペット
  • 技術別スニペット
  • モダリティ別スニペット
  • アプリケーション別スニペット
  • エンドユーザー別スニペット
  • 地域別スニペット

第4章 市場力学

  • 影響要因
    • 促進要因
      • 慢性疾患の増加別外科用画像診断の世界市場拡大
    • 抑制要因
      • 高い機器コストが、外科用画像診断装置の世界市場の成長を阻害しています
    • 機会
      • 技術的進歩
    • 影響分析

第5章 産業分析

  • ポーターの5フォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 法規制分析

第6章 COVID-19の分析

第7章 ロシア・ウクライナ戦争分析

第8章 人工知能の分析

第9章 製品別

  • Cアーム
  • O-アーム
  • Gアーム
  • イメージングアクセサリー
  • その他

第10章 技術別

  • フラットパネルディテクター
  • イメージインテンシファイア
  • その他

第11章 モダリティ別

  • X線
  • MRI
  • CTスキャニング
  • 超音波
  • その他

第12章 アプリケーション別

  • 神経画像診断
  • 整形外科・外傷画像診断
  • 心臓血管画像診断
  • 消化器系画像診断
  • 一般外科用画像診断
  • 泌尿器科画像診断
  • その他

第13章 エンドユーザー別

  • 病院
  • 外来外科クリニック
  • スペシャリティクリニック
  • その他

第14章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第15章 競合情勢

  • 競合シナリオ
  • 製品ベンチマーク
  • 企業シェア分析
  • 主な発展と戦略

第16章 企業プロファイル

  • GE Healthcare
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展状況
  • Medtronic Plc.
  • Siemens Healthineers AG
  • Thales Group
  • Shimadzu Corporation
  • Hitachi Ltd
  • Koninklijke Philips N.V.
  • Ziehm Imaging GmbH
  • OrthoScan Inc.
  • Genoray Co. Ltd.

第17章 付録

目次
Product Code: MD1541

Market Overview

The Global Surgical Imaging Market size reached US$ 2,047.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 3,330.5 billion by 2030. The global surgical imaging market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).

Surgical imaging is crucial in oncological surgeries, including tumor resections, biopsy procedures, and lymph node dissections. Oncologic surgeons are able to optimize the surgical approach and guarantee total tumor excision by using imaging modalities including CT, MRI, and PET-CT scans that aid in tumor localization, staging, and determining precise margins for surgical removal.

Market Dynamics

The Growing Burden Of Chronic Diseases Is Boosting The Global Surgical Imaging Market Growth During The Forecast Period.

In both industrialized and developing countries, chronic non-communicable diseases (NCDs) constitute the main cause of death and disability. Seven out of ten fatalities globally are caused by the four primary NCDs: cancer, cardiovascular disease, chronic respiratory illnesses, and diabetes. Eighty percent of NCD-related deaths take place in low- and middle-income nations.

According to a World Health Organisation (WHO) estimate from 2022, noncommunicable diseases (NCDs) account for 41 million annual deaths or 74% of all fatalities worldwide. 17 million people worldwide pass away from an NCD before they turn 70 each year; 86% of these untimely deaths take place in low- and middle-income nations.

Technological Advancements Are Providing The Surgical Imaging Market With Prospective Growth Opportunities

In order to successfully complement each other's work in the future of surgery, humans and healthcare technology will need to work together more and more. For instance, in January 2022, The Image-Guided Therapy Mobile C-arm System - Zenition, developed by Royal Philips, a health technology organization, will now provide physicians with advanced new 3D image guidance capabilities, enhancing clinical accuracy and efficiency and aim to improve the results for patients receiving endovascular treatment.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the surgical imaging market. Elective surgeries have been postponed globally as a result of the pandemic's substantial and wide-ranging impact on surgical specialties.

As per the article published in Jornal of Minimal Access Surgery in 2022, when compared to traditional open surgery, minimally invasive surgery (MIS) employs a smaller incision, causes less damage to tissues, minimizes blood loss, shortens the time patients must stay in the hospital and produces superior short-term and comparable long-term results. In order to combat this pandemic, surgeons could achieve success in the field of MIS.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the surgical imaging market is complex and multifaceted. During times of conflict, healthcare resources and priorities may shift towards emergency and trauma care, leaving less focus and investment in non-emergency procedures and specialized equipment like surgical imaging systems. The demand for surgical imaging is impacted as healthcare systems prioritize immediate and critical needs over investments in advanced imaging technologies.

Segment Analysis

The global surgical imaging market is segmented based on product, material, distribution channel, end-user, and region.

The Gastrointestinal Imaging Segment Is Expected To Hold A Dominant Position In The Market Over The Forecast Period.

The gastrointestinal imaging segment accounted for the highest market stake accounting for approximately 25.3% of the surgical imaging market in 2022. Surgical imaging plays a significant role in gastrointestinal procedures such as laparoscopic or robotic-assisted surgeries for conditions like colorectal cancer, gallbladder diseases, and bariatric surgery.

Furthermore, in September 2022, the newest surgical visualization platform from Olympus Corporation, a manufacturer of optics and reprography products, VISERA ELITE III, was introduced to meet the needs of healthcare professionals (HCPs) performing endoscopic procedures in a variety of medical specialties. Numerous imaging capabilities provided by VISERA ELITE III, supported by a single system, enable minimally invasive procedures such as laparoscopic colectomy and laparoscopic cholecystectomies.

Geographical Analysis

Increasing Collaborations And Partnerships Among The Key Players, Increasing Chronic Diseases, And Advancement In Surgical Imaging Dominate the North American Region.

North America is expected to dominate the surgical imaging market, accounting for around one-third of this market. The surgical imaging market is driven by factors such as collaborations among key players, and advanced healthcare facilities in the North American region.

For instance, in November 2022, Hospital for Special Surgery (HSS), the top academic medical center in the world for musculoskeletal health, and medical device and technology company Lazurite collaborated based on Lazurite's ArthroFree Wireless Surgical Camera System, the first wireless surgical camera system to be cleared for market by the U.S. Food and Drug Administration for arthroscopy and general endoscopy.

Competitive Landscape

The major global players in the market include: GE Healthcare, Medtronic Plc., Siemens Healthineers AG, Thales Group, Shimadzu Corporation, Hitachi Ltd, Koninklijke Philips N.V., Ziehm Imaging GmbH, OrthoScan Inc., and Genoray Co. Ltd. among others.

Why Purchase the Report?

  • To visualize the global surgical imaging market segmentation based on the product, technology, application, modality, end-users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the surgical imaging market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global surgical imaging market report would provide approximately 77 tables, 82 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Modality
  • 3.4. Snippet by Application
  • 3.5. Snippet by End-users
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the prevalence of chronic diseases is driving the global surgical imaging market growth.
    • 4.1.2. Restraints
      • 4.1.2.1. High equipment cost is hampering the growth of the global surgical imaging market.
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. C-Arms*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. O-Arms
  • 9.4. G-Arms
  • 9.5. Imaging Accessories
  • 9.6. Others

10. By Technology

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.1.2. Market Attractiveness Index, By Technology
  • 10.2. Flat Panel Detectors*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Image Intensifier
  • 10.4. Others

11. By Modality

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.1.2. Market Attractiveness Index, By Modality
  • 11.2. X-Ray*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. MRI
  • 11.4. CT Scanning
  • 11.5. Ultrasound
  • 11.6. Others

12. By Application

    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2. Market Attractiveness Index, By Application
  • 12.2. Neurological Imaging*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Orthopaedic and Trauma Imaging
  • 12.4. Cardiovascular Imaging
  • 12.5. Gastrointestinal Imaging
  • 12.6. General Surgery Imaging
  • 12.7. Urological Imaging
  • 12.8. Others

13. By End-users

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 13.1.2. Market Attractiveness Index, By End-users
  • 13.2. Hospitals*
    • 13.2.1. Introduction
    • 13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 13.3. Ambulatory Surgical Clinics
  • 13.4. Specialty Clinics
  • 13.5. Others

14. By Region

  • 14.1. Introduction
    • 14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 14.1.2. Market Attractiveness Index, By Region
  • 14.2. North America
    • 14.2.1. Introduction
    • 14.2.2. Key Region-Specific Dynamics
    • 14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.2.8.1. The U.S.
      • 14.2.8.2. Canada
      • 14.2.8.3. Mexico
  • 14.3. Europe
    • 14.3.1. Introduction
    • 14.3.2. Key Region-Specific Dynamics
    • 14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.3.8.1. Germany
      • 14.3.8.2. The U.K.
      • 14.3.8.3. France
      • 14.3.8.4. Italy
      • 14.3.8.5. Spain
      • 14.3.8.6. Rest of Europe
  • 14.4. South America
    • 14.4.1. Introduction
    • 14.4.2. Key Region-Specific Dynamics
    • 14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.4.8.1. Brazil
      • 14.4.8.2. Argentina
      • 14.4.8.3. Rest of South America
  • 14.5. Asia-Pacific
    • 14.5.1. Introduction
    • 14.5.2. Key Region-Specific Dynamics
    • 14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.5.8.1. China
      • 14.5.8.2. India
      • 14.5.8.3. Japan
      • 14.5.8.4. Australia
      • 14.5.8.5. Rest of Asia-Pacific
  • 14.6. Middle East and Africa
    • 14.6.1. Introduction
    • 14.6.2. Key Region-Specific Dynamics
    • 14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users

15. Competitive Landscape

  • 15.1. Competitive Scenario
  • 15.2. Product Benchmarking
  • 15.3. Company Share Analysis
  • 15.4. Key Developments and Strategies

16. Company Profiles

  • 16.1. GE Healthcare*
    • 16.1.1. Company Overview
    • 16.1.2. Product Portfolio and Description
    • 16.1.3. Financial Overview
    • 16.1.4. Key Developments
  • 16.2. Medtronic Plc.
  • 16.3. Siemens Healthineers AG
  • 16.4. Thales Group
  • 16.5. Shimadzu Corporation
  • 16.6. Hitachi Ltd
  • 16.7. Koninklijke Philips N.V.
  • 16.8. Ziehm Imaging GmbH
  • 16.9. OrthoScan Inc.
  • 16.10. Genoray Co. Ltd.

LIST NOT EXHAUSTIVE

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us